MedPath
EMA Approval

Porcilis PCV

Authorised

EMEA/V/C/000135

Immunologicals for suidae

adjuvanted inactivated vaccine against porcine circovirus

porcine circovirus type 2 ORF2 subunit antigen

Basic Information

EMA regulatory identification and product classification information

EMA Identifiers

EMA Product NumberEMEA/V/C/000135
EMA European Classification

Overview Summary

Comprehensive product overview and regulatory summary

Up-to-date information on this veterinary medicinal product is available on the Veterinary Medicines Information website

Authorisations (1)

EMEA/V/C/000135

Authorised

Active Substances (1)

porcine circovirus type 2 ORF2 subunit antigen

Documents (7)

Porcilis PCV : EPAR - Summary for the public

January 14, 2009

OVERVIEW_DOCUMENT

Porcilis PCV : EPAR - Product Information

January 20, 2010

DRUG_PRODUCT_INFORMATION

Porcilis PCV : EPAR - Procedural steps taken and scientific information after authorisation

January 20, 2010

CHANGES_SINCE_INITIAL_AUTHORISATION

Porcilis PCV : EPAR - Procedural steps taken before authorisation

January 26, 2009

CHANGES_SINCE_INITIAL_AUTHORISATION

Porcilis PCV : EPAR - Scientific Discussion

January 26, 2009

CHANGES_SINCE_INITIAL_AUTHORISATION

Committee for medicinal products for veterinary use summary of opinion: Porcilis PCV

November 13, 2008

CHANGES_SINCE_INITIAL_AUTHORISATION

Porcilis PCV : EPAR - All Authorised presentations

January 12, 2009

AUTHORISED_PRESENTATIONS

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Porcilis PCV - EMA Approval | MedPath